Natus Medical Incorporated
NTUS · NASDAQ
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.9% | 13% | -1.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 54.6% | 56.8% | 59.5% | 57.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 8.6% | 8.2% | 12.9% | 11.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 1.6% | 1.4% | 4.9% | 3% |
| EPS Diluted | 0.056 | 0.051 | 0.16 | 0.1 |
| % Growth | 8.6% | -68.1% | 60% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |